School of Medicine

“We were able to associate risk of death with the characteristics of the patients’ beta-adrenergic receptor genes,” says study co-author Howard McLeod.

Interferon — a critical protein that mediates the body’s defense against a wide variety of infectious agents and tumors — may soon have greater therapeutic value as the result of a new study by researchers at the School of Medicine.

A monoclonal antibody that can effectively treat mice infected with West Nile virus has an intriguing secret: Contrary to scientists’ expectations, it does not block the virus’s ability to attach to host cells. Instead, the antibody somehow stops the infectious process at a later point.

Survival of heart attack and unstable angina patients placed on beta-blocker therapy corresponds to specific variations in their genes, according to a study by researchers at the School of Medicine and the Mid America Heart Institute in Kansas City.

“This is the largest systematic trial of AIDS treatment to ever be conducted on a multinational stage,” David B. Clifford says. More medical news

High-caliber cancer services are now more proximate to the people of St. Charles and its surrounding communities.

The findings provide a new understanding of how individual cells find their niche during organ development.

Photo by Robert BostonGuests socialize during the Sept. 16 opening celebration of the Farrell Learning and Teaching Center on the Medical Campus.

MilbrandtJeffrey Milbrandt, M.D., Ph.D, professor of pathology and immunology, internal medicine and of neurology, will become the first David Clayson Professor of Neurology on Sept. 22.

Neuroscientists at the School of Medicine have assembled a first-of-its kind atlas of the folds of the cerebral cortex, the wrinkled surface layer of the brain credited with many of the higher cognitive functions that make us human.